Skip to main content

Pregnant Women

1
Pipeline Programs
11
Companies
6
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

11 companies ranked by most advanced pipeline stage

Autonomous Therapeutics
1 program
1
Pregnant women to whom applied silane fluoridePhase 41 trial
Active Trials
NCT04868513Completed58Est. Dec 2017
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
In-home Mentor Mother visitsN/A1 trial
Active Trials
NCT01687634Completed203Est. Jul 2016
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
MelatoninN/A1 trial
Active Trials
NCT05358834Recruiting120Est. Jun 2027
Supernus Pharmaceuticals
1 program
National Pregnancy Registry for Psychiatric MedicationsN/A
Eisai
EisaiChina - Liaoning
1 program
National Pregnancy Registry for Psychiatric MedicationsN/A
Alkermes
AlkermesDUBLIN 4, Ireland
1 program
National Pregnancy Registry for Psychiatric MedicationsN/A
Otsuka
OtsukaJapan - Tokushima
1 program
National Pregnancy Registry for Psychiatric MedicationsN/A
Sage Therapeutics
Sage TherapeuticsMA - Cambridge
1 program
National Pregnancy Registry for Psychiatric MedicationsN/A
Bristol Myers Squibb
1 program
National Pregnancy Registry for Psychiatric MedicationsN/A1 trial
Active Trials
NCT01246765Recruiting5,000Est. Dec 2033
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Normal ironN/A1 trial
Active Trials
NCT03651934Unknown600Est. Jun 2020
Stratpharma
StratpharmaSwitzerland - Basel
1 program
StratamarkN/A1 trial
Active Trials
NCT07467837Recruiting10,000Est. Feb 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Autonomous TherapeuticsPregnant women to whom applied silane fluoride
StratpharmaStratamark
Human BioSciencesMelatonin
UNION therapeuticsNormal iron
Angeles TherapeuticsIn-home Mentor Mother visits
Bristol Myers SquibbNational Pregnancy Registry for Psychiatric Medications

Clinical Trials (6)

Total enrollment: 15,981 patients across 6 trials

NCT04868513Autonomous TherapeuticsPregnant women to whom applied silane fluoride

Streptococcus Mutans Reduction Early Mother-infant Transmission

Start: Jan 2015Est. completion: Dec 201758 patients
Phase 4Completed
NCT07467837StratpharmaStratamark

Prevention of Stretch Marks in Expectant Mothers

Start: Feb 2026Est. completion: Feb 202710,000 patients
N/ARecruiting
NCT05358834Human BioSciencesMelatonin

Testing Effects of Melatonin on Uterine Contractions in Women

Start: Jan 2023Est. completion: Jun 2027120 patients
N/ARecruiting
NCT03651934UNION therapeuticsNormal iron

Verification of Correlation Between Genetic Testing of Nutritional Metabolism and Clinical Biochemical Indicators

Start: Oct 2018Est. completion: Jun 2020600 patients
N/AUnknown
NCT01687634Angeles TherapeuticsIn-home Mentor Mother visits

Home Visiting for Low Income, Pregnant Women

Start: Oct 2012Est. completion: Jul 2016203 patients
N/ACompleted
NCT01246765Bristol Myers SquibbNational Pregnancy Registry for Psychiatric Medications

National Pregnancy Registry for Psychiatric Medications

Start: Nov 2008Est. completion: Dec 20335,000 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 actively recruiting trials targeting 15,981 patients
11 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.